TAMPA, Fla., Dec. 31, 2025 (GLOBE NEWSWIRE) -- FLUENT Corp. (CSE: FNT.U) (OTCQB: CNTMF) (“FLUENT” or the “Company”), today announced that it has completed the sale of its Pennsylvania operations to HIVE Holdings, Inc., effective December 31, 2025 for US$12.5 million in cash. The proceeds from the transaction were used to reduce FLUENT’s outstanding debt, which is expected to meaningfully enhance its balance sheet, allowing the Company to further concentrate capital and operational resources on its core grow ...

Key Takeaways CRON agreed to buy CanAdelaar, gaining a leading position in the Netherlands' regulated adult-use market.Village Farms exited fresh produce, fueling 758% year-over-year growth in Q3 medical cannabis export sales.TLRY is expanding European medical cannabis while using beverages to offset volatility in core operations.2025 shaped up to be a breakthrough year for the cannabis industry. After years of muted growth and battered stock prices, the sector finally began showing signs of life as long-aw ...

TORONTO--(BUSINESS WIRE)--Organigram Global Inc. (NASDAQ: OGI) (TSX: OGI), (the "Company†or "Organigram†), Canada's #1 cannabis company by market share1, today announced the expansion of its innovation investment in Phylos Bioscience Inc. ("Phylos†), securing Organigram's position as a leader in seed-based cannabis genetics. Through an amended loan and product agreement, Organigram gains priority access to Phylos' autoflower genetics pipeline, including preferential economic terms and long-ter. ...

Market Analysis by covering: Canopy Growth Corp, Tilray Inc. Read 's Market Analysis on Investing.com ...

NEW YORK, Dec. 30, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of SNDL Inc. (“SNDL” or the “Company”) (NASDAQ: SNDL).  Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, ext. 7980. The investigation concerns whether SNDL and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.  [Click here for information about joining the class action] On December 15, 2025, SNDL a ...

VANCOUVER, BC / ACCESS Newswire / December 30, 2025 / 1933 Industries Inc. (the "Company" or "1933 Industries") (CSE:TGIF)(OTCID:TGIFF) provides the following update regarding its unsecured convertible debentures issued in 2024 (the "2024 Debentures").Debenture Conversion StatusAs of December 22, 2025, the conversion deadline set out in the debenture agreement, an aggregate of $1,035,000 of debentures were converted into units of the Company. Following these conversions, $1,563,000 of debentures remain o ...

NLCP , better known as NewLake Capital Partners, is a U.S. REIT that operates within the highly regulated cannabis industry within the U.S.. More specifically, NLCP operates a variety of both indoor cultivation assets, as well as dispensaries in variousAs a young professional in the oil and gas engineering space, I seek to leverage my technical and analytical background to gain a deeper understanding of the fundamentals driving not only the energy sector, but global markets as a whole. I have put extensive ...

公司概况 - NewLake Capital Partners 是一家在美国受严格监管的大麻行业内运营的房地产投资信托基金 [1] - 公司运营多种室内种植资产以及分布在各地的药房 [1] 作者背景与立场 - 文章作者披露其通过股票、期权或其他衍生品持有该公司的多头头寸 [1] - 文章观点为作者个人意见 未因撰写本文获得相关公司报酬 [1]

VANCOUVER, British Columbia, Dec. 29, 2025 (GLOBE NEWSWIRE) -- LEEF Brands, Inc. (CSE: LEEF, OTCQB: LEEEF) (“LEEF” or the “Company”), a leading multi-state operator, today announced the full early conversion of all outstanding Canadian-dollar-denominated convertible debentures, in principal amount together with accrued and unpaid interest of approximately CAD $237,000, effective December 15, 2025. This follows the full conversion of ~US$10.5M in convertible debentures announced on December 5, 2025. The conv ...

行业趋势与投资环境 - 大麻行业正在演变成一个规模更大、监管更严的全球市场 合法化趋势在美国和国际地区持续扩大[1] - 成人使用市场推动规模效率和品牌主导地位 医疗大麻的采用则支撑了稳定的收入和防御性的市场定位[1][2] - 联邦改革讨论持续影响投资者情绪和估值 预计2026年的监管明确性可能前所未有地释放机构资本[2] - 大麻股波动性大 提供高风险高回报的可能性 价格波动为有纪律的长期投资者创造了机会[2] - 行业相对于增长潜力而言仍然被低估 对于有见识的投资者 2026年可能带来显著的上涨空间[3] 公司表现与动态 - **Green Thumb Industries Inc (GTBIF)** 在美国从事医疗和成人用大麻产品的制造、分销、营销和销售[4] - Green Thumb Industries 2025年第三季度营收为2.914亿美元 同比增长1.6%[7] - Green Thumb Industries 季度末现金总额为2.262亿美元 运营现金流为7410万美元[7] - Green Thumb Industries 公认会计准则(GAAP)净利润为2330万美元 合每股0.10美元 若剔除资产出售的一次性收益 公认会计准则净利润为970万美元 合每股0.04美元[7] - Green Thumb Industries 调整后息税折旧摊销前利润(Adjusted EBITDA)为8020万美元 占营收的27.5%[7] - **Curaleaf Holdings, Inc (CURLF)** 在美国和国际上生产和分销大麻产品[8] - Curaleaf于12月26日宣布在宾夕法尼亚州Millcreek开设了其在Erie的第二家药房[8] - Curaleaf在宾夕法尼亚州拥有18家门店 在全国拥有159个地点[10] 成功要素与投资策略 - 强劲的资产负债表和领导力是区分赢家与失败者的关键[3] - 在大麻行业不同细分领域进行多元化投资可以降低投资组合风险[3] - 大麻 ancillary 类股票提供了行业敞口 同时避免了直接接触种植业务的风险[3] - 战略时机很重要 市场周期会回报有耐心的投资者[3] - 宏观经济稳定可能进一步支持大麻股的表现[3]